Figure 1.
(a) Positron emission tomography‐computed tomography (PET/CT) scan before chemoradiotherapy; (b) a CT of the chest revealed the recurrence of lung lesions after the course of chemoradiotherapy; (c) CT scan of chest after two months of crizotinib treatment.